European Journal of Pharmacology 1997: Vol 324 Index

11 Pages·1997·2.1 MB·English

co
ELSEVIER European Journal of Pharmacology 324 (1997) 305—307
Author index
Adachi, Y.. Hashimoto, K., Ono, N.. Yoshida, M., Suzuki-Kusaba, M.. Diop. L.. see Langlois, A. (324) 211
Hisa, H. and Satoh, S. Dyer, D.C., see Hu, X.-Q. (324) 67
Renal effects of a nitric oxide donor, NOC7 , in anesthetized rabbits
(324) 223 Eckly-Michel, A.E.. Le Bec, A. and Lugnier, C.
Andrighetto, G., see Conforti, A. (324) 241 Chelerythrine, a protein kinase C inhibitor, interacts with cyclic
Angulo, J., see Peiré, C, (324) 257 nucleotide phosphodiesterases (324) 85
Anselmi, E., see Pinto, F.M. (324) 125 El-Metwally, M., Shafiee-Nick. R.. Pyne, NJ. and Furman, B.L.
Ashby Jr.. C.R.. see Gifford, A.N. (324) 187 The effect of selective phosphodiesterase inhibitors on plasma insulin
Ausina, P., see Pinto, F.M. (324) 125 concentrations and insulin secretion in vitro in the rat (324) 227
Bachelet, M., see Bureau, M.F. (324) 89 Féray. J.-C., see Taouil, K. (324) 289
Baczk6, 1., Lepran, |. and Papp, J.Gy. Fleckenstein, A.E., Beyeler. M.L.. Jackson, J.C... Wilkins, D.G.. Gibb.
K,rp channel modulators increase survival rate during coronary J.W. and Hanson, G.R.
occlusion-reperfusion in anaesthetized rats (324) 77 Methamphetamine-induced decrease in tryptophan hydroxylase activ-
Back, H.-J.. see Sim, S.-S. (324) 205 ity: role of 5-hydroxytryptaminergic transporters (324) 179
Baldi, A.. see Shayo, C.C. (324) 129 Fontana, DJ.. see Hunter, J.C. (324) 153
Barnes, P.J., see Takahashi, T. (324) 219 Friese, N., see Langlois, A. (324) 211
Bellavite, P.. see Conforti, A. (324) 241 Fujiki, H., see Hirano, T. (324) 201
Belvisi, M.G., see Takahashi, T. (324) 219 Fujita, N., see Ikeda, M. (324) 283
Berdeu, D.. Puech, R.. Ribes, G.. Loubatitres-Mariani, M.-M. and Funada, M.. see Sora, 1. (324) RI
Bertrand, G. Furman, B.L.. see El-Metwally, M. (324) 227
Antazoline increases insulin secretion and improves glucose tolerance Furukawa, H., see Noda, Y. (324) 135
in rats and dogs (324) 233
Bertani, S., see Conforti, A. (324) 241 Garay, R.P., see Taouil, K. (324) 289
Bertrand, G., see Berdeu, D. (324) 233 Gatley, S.J., see Gifford, A.N. (324) 187
Beyeler, M.L.. see Fleckenstein, A.E. (324) 179 George, S.R., see Jin, H. (324) 109
Bowman, C.J., see Tiimer, N. (324) 57 Germonpré, P.R.. Joos, G.F., Mekeirele, K. and Pauwels, R.A.
Bruggeman, R., Westerink, B.H.C. and Timmerman, W. Role of the 5-HT receptor in neurogenic inflammation in Fisher 344
Effects of risperidone, clozapine and haloperidol on extracellular rat airways (324) 249
recordings of substantia nigra reticulata neurons of the rat brain (324) Gibb, J.W.. see Fleckenstein, A.E. (324) 179
49 Gifford, A.N., Samiian, L., Gatley, SJ. and Ashby Jr., C.R.
Brunet, J., see Taouil, K. (324) 289 Examination of the effect of the cannabinoid receptor agonist, CP
Bureau, M.F., De Castro, C.M.B., Cortese. C.. Bachelet, M. and Var- 55.940, on electrically evoked transmitter release from rat brain slices
gaftig, B.B. (324) 187
5-Lipoxygenase and endotoxin-induced microvascular albumin ex- Gogas, K.R., see Hunter, J.C. (324) 153
changes and leucocyte recruitment in guinea-pig lungs (324) 89 Groenink, L., see Compaan, J.C. (324) 161
Candenas, M.L., see Pinto, F.M. (324) 125 Hahn, S.-J., see Sim, S.-S. (324) 205
Chen, N.-H., see Reith, M.E.A. (324) | Hannaert, P., see Taouil, K. (324) 289
Choi, R.T., see McPherson, G.A. (324) 193 Hanson. G.R.. see Fleckenstein, A.E. (324) 179
Christen, M.-O., see Taouil, K. (324) 289 Hara, Y. and Nakaya, H.
Compaan, J.C., Groenink, L.. Van der Gugten, J.. Maes, R.A.A. and Dual effects of extracellular ATP on the muscarinic acetylcholine
Olivier, B. receptor-operated K~ current in guinea-pig atrial cells (324) 295
Pretreatment with 5-HT,, receptor agonist flesinoxan attenuates Fos Harris, L.S.. see Martin, TJ. (324) 141
protein in rat hypothalamus (324) 161 Hashimoto, K., see Adachi, Y. (324) 223
Conforti, A.. Lussignoli, S.. Bertani, S.. Verlato, G.. Ortolani, R.. Hedley. L.R.. see Hunter, J.C. (324) 153
Bellavite. P. and Andrighetto, G. Hirano, T., Ohura, M., Orito, K.. Fujiki, H.. Miyakoda, G. and Mori, T.
Specific and long-lasting suppression of rat adjuvant arthritis by Venodilator effects of pranidipine, a |.4-dihydropyridine Ca** chan-
low-dose Mycobacterium butyricum (324) 241 nel antagonist, in rats: comparison with nifedipine and amlodipine
Cortese, C., see Bureau, M.F. (324) 89 (324) 201
Hisa, H., see Adachi, Y. (324) 223
Dahl, S.G., see Langlois, A. (324) 211 Hu, S.. Kim, H.S., Savage, P. and Jeng. A.Y.
De Castro, C.M.B., see Bureau, M.F. (324) 89 Activation of BK,., channel via endothelin ET, receptors in porcine
De Costa, B.R., see Zambon, A.C. (324) 39 coronary artery smooth muscle cells (324) 277
306 Author index
Hu, X.-Q. and Dyer, D.C. Maj. J., Rog6éz, Z., Skuza, G. and Kotodziejezyk, K.
Heterogeneity and complexity of a ,-adrenoceptors in the ovine uter- The behavioural effects of pramipexole, a novel dopamine receptor
ine artery and umbilical vein (324) 67 agonist (324) 31
Hunter, J.C., Gogas, K.R., Hedley, L.R., Jacobson, L.O., Kassotakis, L., Mamiya, T., see Noda, Y. (324) 135
Thompson, J. and Fontana, D.J. Martin, J.D., see Pinto, F.M. (324) 125
The effect of novel anti-epileptic drugs in rat experimental models of Martin, T.J., Kim, S.A., Harris, L.S. and Smith, J.E.
acute and chronic pain (324) 153 Potent reinforcing effects of dihydroetorphine in rats (324) 141
Matsumoto, R.R., see Zambon, A.C. (324) 39
Ikeda, M., Ikeda, U., Shimada, K., Fujita, N.. Okada, K., Saito, T., McPherson, G.A., Choi, R.T., Kong, D.C.M. and Iskander, M.N.
Minota, S. and Kano, S. The thromboxane A, and K , 7p channel antagonist actions of a series
Tranilast inhibits the growth of rat mesangial cells (324) 283 of sulphonylurea derivatives in the pig coronary artery (324) 193
Ikeda, U., see Ikeda, M. (324) 283 Mekeirele, K., see Germonpré, P.R. (324) 249
Iskander, M.N., see McPherson, G.A. (324) 193 Minota, S., see Ikeda, M. (324) 283
Misawa, M., see Suzuki, T. (324) 21
Misawa, M., see Tsuda, M. (324) 63
Jackson, J.C., see Fleckenstein, A.E. (324) 179
Miyakoda, G., see Hirano, T. (324) 201
Jacobson, L.O., see Hunter, J.C. (324) 153
Mladovan, A.G., see Shayo, C.C. (324) 129
Jeng, A.Y., see Hu, S. (324) 277
Mori, T., see Hirano, T. (324) 201
Jin, H., Zastawny, R., George, S.R. and O° Dowd, B.F.
Mori, T., see Suzuki, T. (324) 21
Elimination of palmitoylation sites in the human dopamine D, recep-
tor does not affect receptor-G protein interaction (324) 109
Nabeshima, T., see Noda, Y. (324) 135
Jo, Y.-H., see Sim, S.-S. (324) 205
Nagase, H., see Suzuki, T. (324) 21
Joos, G.F., see Germonpré, P.R. (324) 249
Nakaya, H., see Hara, Y. (324) 295
Junien, J.-L., see Langlois, A. (324) 211
Nguyen, B.Q.H., see Zambon, A.C. (324) 39
Niggli, V. and Keller, H.
Kameyama, T., see Ukai, M. (324) 147
Low concentrations of the phosphatase inhibitor okadaic acid stop
Kano, S., see Ikeda, M. (324) 283
tumor cell locomotion (324) 99
Kanthasamy, A.G., see Zambon, A.C. (324) 39
Noda, Y., Mamiya, T., Furukawa, H. and Nabeshima, T.
Kassotakis, L., see Hunter, J.C. (324) 153
Effects of antidepressants on phencyclidine-induced enhancement of
Kawikova, I., see Takahashi, T. (324) 219
immobility in a forced swimming test in mice (324) 135
Keller, H., see Niggli, V. (324) 99
Kelley, A., see Tiimer, N. (324) 57
O'Dowd, B.F., see Jin, H. (324) 109
Kim, H.S., see Hu, S. (324) 277
Ogihara, M., see Kimura, M. (324) 267
Kim, M.-S., see Sim, S.-S. (324) 205
Ohura, M., see Hirano, T. (324) 201
Kim, S.A., see Martin, TJ. (324) 141
Okada, K., see Ikeda, M. (324) 283
Kimes, A.S., see Vaupel, D.B. (324) 11
Olivier, B., see Compaan, J.C. (324) 161
Kimura, M. and Ogihara, M.
Ono, N., see Adachi, Y. (324) 223
Density-dependent proliferation of adult rat hepatocytes in primary
Orito, K., see Hirano, T. (324) 201
culture induced by epidermal growth factor is potentiated by cAMP-
Ortolani, R., see Conforti, A. (324) 241
elevating agents (324) 267
Kishimoto, Y., see Suzuki, T. (324) 21
Papp, J.Gy., see Baczk6, I. (324) 77
Kolodziejczyk, K., see Maj, J. (324) 31
Pascaud, X., see Langlois, A. (324) 211
Kong, D.C.M., see McPherson, G.A. (324) 193
Pauwels, R.A., see Germonpré, P.R. (324) 249
Kovacs, K.J. and Larson, A.A.
Peiré, C.. Angulo, J., Regadera, J., Llergo, J.L.. Sanchez-Ferrer, A..,
Zn** inhibition of [‘HJMK-801 binding is different in mouse brain
Rodriguez-Maiias, L. and Sanchez-Ferrer, C.F.
and spinal cord: effect of glycine and glutamate (324) 117
Nifedipine, losartan and captopril effects on hyperplasia of vascular
smooth muscle from Ren-2 transgenic rats (324) 257
Langlois, A., Diop, L., Friese, N., Pascaud, X., Junien, J.-L., Dahl, S.G. Pinto, F.M., Magraner, J.. Ausina, P., Anselmi, E.. Martin, J.D. and
and Riviere, P.J.M. Candenas, M.L.
Fedotozine blocks hypersensitive visceral pain in conscious rats: Regulation by oestrogens of tachykinin NK, receptor expression in
action at peripheral K-opioid receptors (324) 211 the rat uterus (324) 125
LaRochelle, J.S., see Timer, N. (324) 57 Puech, R., see Berdeu, D. (324) 233
Larson, A.A., see Kovacs, K.J. (324) 117 Pyne, N.J., see El-Metwally, M. (324) 227
Lawand, N.B., Willis, W.D. and Westlund, K.N.
Excitatory amino acid receptor involvement in peripheral nociceptive Regadera, J., see Peiré, C. (324) 257
transmission in rats (324) 169 Reith, M.E.A., Xu, C. and Chen, N.-H.
Le Bec, A., see Eckly-Michel, A.E. (324) 85 Pharmacology and regulation of the neuronal dopamine transporter
Lepran, I., see Baczk6, I. (324) 77 (324) |
Llergo, J.L., see Peiré, C. (324) 257 Rhie, D.-J., see Sim, S.-S. (324) 205
London, E.D., see Vaupel, D.B. (324) 11 Ribes, G., see Berdeu, D. (324) 233
Loubatiéres-Mariani, M.-M., see Berdeu, D. (324) 233 Riviere, P.J.M., see Langlois, A. (324) 211
Lugnier, C., see Eckly-Michel, A.E. (324) 85
Rodriguez-Maiias, L., see Peiré, C. (324) 257
Lussignoli, S., see Conforti, A. (324) 241 Rog6z, Z., see Maj, J. (324) 31
Maeda, J., see Suzuki, T. (324) 21 Saito, T., see Ikeda, M. (324) 283
Maes, R.A.A., see Compaan, J.C. (324) 161 Samiian, L., see Gifford, A.N. (324) 187
Magraner, J., see Pinto, F.M. (324) 125 Sanchez-Ferrer, A., see Peiré, C. (324) 257
Author index
Sanchez-Ferrer, C.F. see Peiré, C. (324) 257 Tsuji, M., see Suzuki, T. (324) 21
Satoh, S.. see Adachi, Y. (324) 223 Timer, N.. Bowman, CJ., LaRochelle, J.S.. Kelley. A. and Scarpace. PJ.
Savage, P.. see Hu, S. (324) 277 Induction of tyrosine hydroxylase by forskolin: modulation with age
Scarpace, PJ., see Tiimer, N. (324) 57 (324) 57
Shafiee-Nick, R.. see El-Metwally, M. (324) 227
Shayo, C.C., Mladovan, A.G. and Baldi. A.
Uhl. G.R.. see Sora, L. (324) RI
Differentiating agents modulate topoisomerase | activity in U-937
promonocytic cells (324) 129 Ukai, M., Tanaka, T. and Kameyama, T.
Shimada, K., see Ikeda, M. (324) 283 Effects of the dopamine D, receptor agonist, R( + )-7-hydroxy- N.N-
Sim, S.-S.. Baek, H.-J.. Yoon, S.-H.. Rhie, D.-J.. Hahn, S.-J.. Jo. Y.-H. di-n-propy!-2-aminotetralin, on memory processes in mice (324) 147
and Kim, M.-S.
Regulation of protein kinases in steady-state contraction of cat gastric Van der Gugten, J., see Compaan, J.C. (324) 161
smooth muscle (324) 205 Vargaftig. B.B.. see Bureau, M.F. (324) 89
Skuza, G., see Maj, J. (324) 31 Vaupel. D.B.. Kimes. A.S. and London, E.D
Smith, J.E., see Martin, TJ. (324) 141
Further in vivo studies on attenuating morphine withdrawal: isoform-
Sora, L., Funada, M. and Uhl, G.R.
selective nitric oxide synthase inhibitors differ in efficacy (324) 11
The 1-opioid receptor is necessary for [D-Pen* .p>-Pen*J enkephalin-in- Verlato, G., see Conforti, A. (324) 241
duced analgesia (324) R!
Suzuki-Kusaba, M., see Adachi, Y. (324) 223
Suzuki, T.. Mori, T.. Tsuji, M.. Maeda, J.. Kishimoto, Y.. Misawa, M. Warner. T.D.. see Takahashi, T. (324) 219
and Nagase. H. Westerink, B.H.C.. see Bruggeman, R. (324) 49
Differential effects of p-, 5- and x-opioid receptor agonists on the Westlund, K.N., see Lawand, N.B. (324) 169
discriminative stimulus properties of cocaine in rats (324) 21 Wilkins, D.G., see Fleckenstein, A.E. (324) 179
Suzuki, T.. see Tsuda, M. (324) 63 Willis, W.D.. see Lawand, N.B. (324) 169
Takahashi, T.. Barnes, PJ.. Kawikova, 1. Yacoub, M.H.. Warner, T.D.
and Belvisi, M.G. Xu, C., see Reith, M.E.A. (324) I
Contraction of human airway smooth muscle by endothelin-1 and IRL
1620: effect of bosentan (324) 219 Yacoub, M.H.. see Takahashi, T. (324) 219
Tanaka, T., see Ukai, M. (324) 147
Yoon, S.-H., see Sim, S.-S. (324) 205
Taouil, K.. Féray, J.-C.. Brunet, J.. Christen, M.-O., Garay, R.P. and
Yoshida, M., see Adachi, Y. (324) 223
Hannaert, P.
Inhibition by xipamide of amiloride-induced acidification in cultured
rat cardiocytes (324) 289 Zambon, A.C., De Costa, B.R.. Kanthasamy. A.G., Nguyen, B.Q.H. and
Thompson, J., see Hunter, J.C. (324) 153 Matsumoto, R.R.
Timmerman, W., see Bruggeman, R. (324) 49 Subchronic administration of N-(2-(3.4-dichloropheny|ethyl}-N-
Tsuda, M., Suzuki, T. and Misawa, M. methyl-2(dimethylaminoethylamine (BD1047) alters o, receptor
Recovery of decreased seizure threshold for pentylenetetrazole during binding (324) 39
diazepam withdrawal by NMDA receptor antagonists (324) 63 Zastawny. R., see Jin, H. (324) 109

co
ELSEVIER European Journal of Pharmacology 324 (1997) 309-315
Keyword index
Acetylcholine Anesthetized rat
Cannabinoid receptor, CP 55,940; SR 141716A; Brain slice (Gifford, Reperfusion arrhythmia; Pinacidil; Cromakalim: Glibenclamide (Baczk6,
A.N. (324) 187) 1. (324) 77)
6-Acetylmorphine Angiotensin II
Fentanyl: Heroin; Morphine: Reinforcement (Martin, TJ. (324) 141) Norepinephrine, NOC 7 (1-hydroxy-2-oxo-34 N-methyl-3-aminopropy!)-
3-methy! |-triazene); Nitric oxide (NO), Kidney: (Rabbit) (Adachi, Y
Action potential duration (324) 223)
ATP. extracellular, Muscarinic acetylcholine receptor-operated K* cur-
rent; Atrial cell; Purinoceptor (Hara, Y. (324) 295) Antazoline
Imidazoline: Insulin secretion: Somatostatin secretion: Glucose tolerance:
Adenyly! cyclase Pancreas; (Rat), (Dog) (Berdeu, D. (324) 233)
Dopamine: Dopamine D, receptor: Palmitoylation: Desensitization Vin,
H. (324) 109) Antidepressant
Phencyclidine; Schizophrenia, negative symptom: Depression; 5-HT (5-
Adjuvant arthritis
hydroxytryptamine, serotonin), Forced swimming test, (Mouse) (Noda, Y
Cytokine; Immunoregulation (Conforti, A. (324) 241) (324) 135)
Adrenal medulla
Antinociception
Catecholamine synthesis; (F-344 rat) (Timer, N. (324) 57)
Neuropathic pain; Allodynia; Tail-flick test; Behavior: Electroshock test,
maximal; Lamotrigine; Felbamate; Gabapentin (Hunter, J.C. (324) 153)
a ,-Adrenoceptor, subtype
Ca** ; Uterine artery; Umbilical vein (Hu, X.-Q. (324) 67)
Antiparkinsonian potential activity
Pramipexole; Dopamine receptor agonist; Antipsychotic potential activity
{-Adrenoceptor agonist
(Maj, J. (324) 31)
EGF (epidermal growth factor); Forskolin: DNA synthesis; Hepatocyte
proliferation (Kimura, M. (324) 267)
Antipsychotic
Substantia nigra reticulata; Schizophrenia; Basal ganglion; Electro-
Airways
physiology: Dopamine: 5-HT (S-hydroxytryptamine. serotonin) (Brugge-
Plasma protein extravasation, 5-HT receptor; Histamine receptor;
Tachykinin: Capsaicin; (Fisher 344 rat) (Germonpré, P.R. (324) 249) man, R. (324) 49)
Albumin leakage Antipsychotic potential activity
Lipopolysaccharide; 5-Lipoxygenase; Leukocyte: Lung: Radioactive tracer Pramipexole: Dopamine receptor agonist: Antiparkinsonian potential ac-
(Bureau, M.F. (324) 89) tivity (Maj, J. (324) 31)
Allodynia Arachidonic acid
Dopamine transporter; WIN 35,428 binding: Protein kinase C; Parkinson's
Neuropathic pain; Antinociception; Tail-flick test; Behavior; Electroshock
test, maximal; Lamotrigine; Felbamate; Gabapentin (Hunter, J.C. (324) disease; Drug abuse (Reith, M.E.A. (324) 1)
153)
ATP, extracellular
NMDA receptor; Non-NMDA glutamate receptor; Nociception; Hyperal- Muscarinic acetylcholine receptor-operated K*° current; Atrial cell;
gesia: Inflammation; Pain (Lawand, N.B. (324) 169) Purinoceptor, Action potential duration (Hara, Y. (324) 295)
Amiloride Atrial cell
Diuretic: Xipamide; Cardiocyte; H9c2 heart cell line; Cell membrane; ATP, extracellular; Muscarinic acetylcholine receptor-operated K~ cur-
(Rat, newborn) (Taouil, K. (324) 289) rent; Purinoceptor; Action potential duration (Hara, Y. (324) 295)
Aminoguanidine Basal ganglion
Morphine withdrawal; Blood pressure; Nitric oxide (NO) synthase in- Substantia nigra reticulata; Antipsychotic; Schizophrenia; Electro-
hibitor; 3-Bromo-7-nitro indazole; S-Methyl-L-thiocitrulline; 7-Nitro in- physiology: Dopamine; 5-HT (5-hydroxytryptamine, serotonin) (Brugge-
dazole; Nitric oxide (NO) (Vaupel, D.B. (324) 11) man, R. (324) 49)
Amygdala, central Bed nucleus of the stria terminalis
Immediate-early gene; Bed nucleus of the stria terminalis; Paraventricular Immediate-early gene: Amygdala, central; Paraventricular nucleus of the
nucleus of the hypothalamus; Corticosterone; CRH (corticotropin-releas- hypothalamus; Corticosterone; CRH (corticotropin-releasing hormone)
ing hormone) (Compaan, J.C. (324) 161) (Compaan, J.C. (324) 161)
310 Keyword index
Behavior Cell membrane
Neuropathic pain; Allodynia; Antinociception; Tail-flick test; Electro- Diuretic; Xipamide; Amiloride; Cardiocyte; H9c2 heart cell line; (Rat,
shock test, maximal; Lamotrigine; Felbamate; Gabapentin (Hunter, J.C. newborn) (Taouil, K. (324) 289)
(324) 153)
Chelerythrine
Blood pressure Protein kinase C; Phosphodiesterase, cyclic nucleotide; Vasorelaxation;
Morphine withdrawal: Nitric oxide (NO) synthase inhibitor; 3-Bromo-7- SK&F 94120; Isoprenaline (Eckly-Michel, A.E. (324) 85)
nitro indazole; Aminoguanidine; $-Methyl-L-thiocitrulline; 7-Nitro inda-
zole; Nitric oxide (NO) (Vaupel, D.B. (324) 11) 7-Chlorokynurenic acid
NMDA receptor; MK-801; Ifenprodil; Diazepam withdrawal; (Mouse)
Bosentan (4-tert-butyl-N-[6-(2-hydroxy-ethoxy )-5-(2-methoxy-phe- (Tsuda, M. (324) 63)
noxy)-2,2'-bipyrimidin-4-yl]-benzene sulfonamide)
Endothelin-1; IRL 1620 (Suc-{Glu’Ala'''*Jendothelin-148-21)), FR Circulatory filling pressure, mean
139317 ((R)2-[( R)-2-{CS)-2-[[| (hexahydro-| H-azepiny|)Jcarbonyl) ami- Pranidipine (OPC-13340), Ca** channel antagonist; Venodilator effect;
no-4-methy|pentanoilJamino-3-{3-(1-methy|- 1 H-indoy!)]propiony|Jamino- (Rat) (Hirano, T. (324) 201)
3-(2-pyridyl) propionic acid) (Takahashi, T. (324) 219)
Cocaine
Brain slice Opioid; Drug discrimination; Drug interaction (Suzuki, T. (324) 21)
Cannabinoid receptor; CP 55,940; SR 141716A; Acetylcholine (Gifford,
A.N. (324) 187) Colonic hypersensitivity
Fedotozine; x-Opioid receptor; 4-Opioid receptor: Visceral pain; (Col-
3-Bromo-7-nitro indazole onic distension) (Langlois, A. (324) 211)
Morphine withdrawal; Blood pressure; Nitric oxide (NO) synthase in-
hibitor, Aminoguanidine; $-Methyl-L-thiocitrulline; 7-Nitro indazole; Ni- Coronary artery, pig
tric oxide (NO) (Vaupel, D.B. (324) 11) Sulphonylurea; Levcromakalim; Thromboxane A ,; U46619; Structure-ac-
tivity relationship (McPherson, G.A. (324) 193)
Ca**
a ,-Adrenoceptor, subtype; Uterine artery; Umbilical vein (Hu, X.-Q. Corticosterone
(324) 67) Immediate-early gene; Amygdala, central; Bed nucleus of the stria termi-
nalis; Paraventricular nucleus of the hypothalamus; CRH (corticotropin-
Ca** channel antagonist releasing hormone) (Compaan, J.C. (324) 161)
Pranidipine (OPC- 13340), Circulatory filling pressure, mean; Venodilator
effect; (Rat) (Hirano, T. (324) 201) CP 55,940
Cannabinoid receptor; SR 141716A; Brain slice; Acetylcholine (Gifford,
Protein kinase C; Calmodulin; Tyrosine kinase; Smooth muscle contrac- A.N. (324) 187)
tion (Sim, S.-S. (324) 205)
CRH (corticotropin-releasing hormone)
Calmodulin Immediate-early gene; Amygdala, central; Bed nucleus of the stria termi-
Ca** channel antagonist; Protein kinase C; Tyrosine kinase; Smooth nalis; Paraventricular nucleus of the hypothalamus; Corticosterone (Com-
muscle contraction (Sim, S.-S. (324) 205) paan, J.C. (324) 161)
Calyculin A Cromakalim
Okadaic acid; Phosphatase; Tumor cell locomotion; Walker 256 carci- Reperfusion arrhythmia; Pinacidil; Glibenclamide; Anesthetized rat
nosarcoma cell; Vimentin (Niggli, V. (324) 99) (Baczk6, I. (324) 77)
Cannabinoid receptor Cytokine
CP 55,940; SR 141716A; Brain slice; Acetylcholine (Gifford, A.N. (324) Adjuvant arthritis; Immunoregulation (Conforti, A. (324) 241)
187)
Cytotoxicity
Capsaicin o Receptor; Regulation; Internalization; (+ )-Pentazocine: Desensitiza-
Plasma protein extravasation; 5-HT receptor; Histamine receptor: tion (Zambon, A.C. (324) 39)
Tachykinin; Airways; (Fisher 344 rat) (Germonpré, P.R. (324) 249)
Depression
Captopril Phencyclidine; Antidepressant; Schizophrenia, negative symptom; 5-HT
Hyperplasia; Smooth muscle, vascular; Cell culture; Nifedipine; Losartan; (5-hydroxytryptamine, serotonin); Forced swimming test; (Mouse) (Noda,
Transgenic rat (Peiré, C. (324) 257) Y. (324) 135)
Cardiocyte Desensitization
Diuretic; Xipamide; Amiloride; H9c2 heart cell line; Cell membrane; o Receptor; Cytotoxicity; Regulation; Internalization; (+ )-Pentazocine
(Rat, newborn) (Taouil, K. (324) 289) (Zambon, A.C. (324) 39)
Catecholamine synthesis Dopamine; Dopamine D, receptor; Palmitoylation; Adenyly! cyclase UJin,
Adrenal medulla; (F-344 rat) (Timer, N. (324) 57) H. (324) 109)
Cell culture Diazepam withdrawal
Hyperplasia; Smooth muscle, vascular; Nifedipine; Captopril; Losartan; NMDA receptor; MK-801; 7-Chlorokynurenic acid; Ifenprodil; (Mouse)
Transgenic rat (Peiré, C. (324) 257) (Tsuda, M. (324) 63)
Keyword index
Differentiation Endothelin-1
Topoisomerase 1; U-937 cell (Shayo, C.C. (324) 129) Bosentan (4-tert-buty!-N-{6-(2-hydroxy-ethoxy }-5-(2-methoxy-phenoxy )-
2,2'-bipyrimidin-4-yl}-benzene sulfonamide); IRL 1620 (Suc-{Glu’,
Diuretic Ala'':'* Jendothelin-148-21)); FR 139317 ((R)2-4{( R)-24(S)-2-4 | Ahexa-
Xipamide; Amiloride; Cardiocyte; H9c2 heart cell line; Cell membrane: hydro-| H-azepiny!)}carbonyl] _amino-4-methylpentanoil Jamino-3-[3-(1-
(Rat, newborn) (Taouil, K. (324) 289) methyl- |H -indoy!))propiony!jamino-3-(2-pyridyl) propionic acid) (Taka-
hashi, T. (324) 219)
DNA synthesis
K* channel, Ca**-activated; Endothelin-3; Endothelin ET, receptor;
EGF (epidermal growth factor), B-Adrenoceptor agonist; Forskolin; Hep-
atocyte proliferation (Kimura, M. (324) 267) Patch-clamp (Hu, S. (324) 277)
Dopamine Endothelin-3
Substantia nigra reticulata; Antipsychotic; Schizophrenia; Basal ganglion: K* channel, Ca**-activated; Endothelin-1; Endothelin ET, receptor;
Electrophysiology; 5-HT (5-hydroxytryptamine, serotonin) (Bruggeman, Patch-clamp (Hu, S. (324) 277)
R. (324) 49)
Endothelin ET, receptor
K* channel, Ca**-activated; Endothelin-1; Endothelin-3; Patch-clamp
Dopamine D, receptor, Palmitoylation; Adenylyl cyclase; Desensitization
(Hu, S. (324) 277)
Gin, H. (324) 109)
Fedotozine
Dopamine D, receptor
«-Opioid receptor, »-Opioid receptor, Visceral pain: Colonic hypersensi-
Dopamine; Palmitoylation; Adenyly! cyclase; Desensitization Vin, H. tivity; (Colonic distension) (Langlois, A. (324) 211)
(324) 109)
Felbamate
Dopamine D, receptor Neuropathic pain; Allodynia; Antinociception; Tail-flick test; Behavior:
R4 + )-7-OH-DPAT (R-( + )-7-hydroxy-N, N-(di-n-propyl-2-aminohetra- Electroshotcekst , maximal; Lamotrigine: Gabapentin (Hunter, J.C. (324)
lin), Passive avoidance learning: Spontaneous locomotor activity; Mem- 153)
ory; (Mouse) (Ukai, M. (324) 147)
Fentanyl!
Dopamine receptor agonist Heroin; Morphine; 6-Acetylmorphine; Reinforcement (Martin, TJ. (324)
Pramipexole; Antipsychotic potential activity; Antiparkinsonian potential 141)
activity (Maj, J. (324) 31)
Fluoxetine
Dopamine transport Methamphetamine; Hyperthermia; Dopamine transport; 5-HT (S-hydroxy-
Methamphetamine; Hyperthermia; Fluoxetine; 5-HT (5-hydroxytrypta- tryptamine, serotonin) (Fleckenstein, A.E. (324) 179)
mine, serotonin) (Fleckenstein, A.E. (324) 179)
Forced swimming test
Dopamine transporter Phencyclidine; Antidepressant; Schizophrenia, negative symptom; De-
WIN 35,428 binding; Arachidonic acid; Protein kinase C; Parkinson's pression; 5-HT (5-hydroxytryptamine, serotonin); (Mouse) (Noda, Y.
disease; Drug abuse (Reith, M.E.A. (324) 1) (324) 135)
DPDPE (\p-Pen?.p-Pen* lenkephalin) Forskolin
5-Opwoid receptor; 4-Opioid receptor knockout mouse (Sora, I. (324) R1) EGF (epidermal growth factor), B-Adrenoceptor agonist; DNA synthesis:
Hepatocyte proliferation (Kimura, M. (324) 267)
Drug abuse
FR 139317 ((R)2-[(R)-2-1(S)-2-[11-(Hh-eazxeapihnyyld) rkoca-r1bo -
Dopamine transporter; WIN 35,428 binding: Arachidonic acid; Protein
nyl] amino-4-methylpentanoil lamino-3-|3-(1-methyl-1 H-indoy!)]
kinase C; Parkinson's disease (Reith, M.E.A. (324) 1)
propiony!lamino-3-(2-pyridyl) propionic acid)
Endothelin-1; Bosentan (4-tert-butyl-N-{6-(2-hydroxy-ethoxy )-5-(2-meth-
Drug discrimination
oxy-phenoxy)-2,2’-bipyrimidin-4-yl}-benzene sulfonamide), IRL 1620
Cocaine; Opioid; Drug interaction (Suzuki, T. (324) 21)
(Suc-{Glu’ Ala''-'* Jendothelin-148-21)) (Takahashi, T. (324) 219)
Drug interaction
Gabapentin
Cocaine; Opioid; Drug discrimination (Suzuki, T. (324) 21)
Neuropathic pain; Allodynia; Antinociception; Tail-flick test; Behavior;
Electroshock test, maximal; Lamotrigine; Felbamate (Hunter, J.C. (324)
EGF (epidermal growth factor) 153)
B-Adrenoceptor agonist; Forskolin; DNA synthesis; Hepatocyte prolifera-
tion (Kimura, M. (324) 267) Glibenclamide
Reperfusion arrhythmia; Pinacidil; Cromakalim; Anesthetized rat (Baczk6,
Electrophysiology 1. (324) 77)
Substantia nigra reticulata; Antipsychotic; Schizophrenia; Basal ganglion;
Dopamine; 5-HT (5-hydroxytryptamine, serotonin) (Bruggeman, R. (324) Glomerulonephritis
49) Nitric oxide (NO); Prostacyclin (Ikeda, M. (324) 283)
Electroshock test, maximal Glucose, plasma
Neuropathic pain; Allodynia; Antinociception; Tail-flick test; Behavior; Org 9935; Org 30029; Insulin secretion; Phosphodiesterase inhibitor;
Lamotrigine; Felbamate; Gabapentin (Hunter, J.C. (324) 153) Insulin, plasma (El-Metwally, M. (324) 227)
312 Keyword index
Glucose tolerance Insulin, plasma
Imidazoline; Antazoline; Insulin secretion; Somatostatin secretion; Pan- Org 9935; Org 30029; Insulin secretion; Phosphodiesterase inhibitor;
creas; (Rat); (Dog) (Berdeu, D. (324) 233) Glucose, plasma (El-Metwally, M. (324) 227)
H9c2 heart cell line Insulin secretion
Diuretic; Xipamide; Amiloride; Cardiocyte; Cell membrane; (Rat, new- Org 9935; Org 30029; Phosphodiesterase inhibitor; Insulin, plasma; Glu-
born) (Taouil, K. (324) 289) cose, plasma (El-Metwally, M. (324) 227)
Imidazoline; Antazoline; Somatostatin secretion: Glucose tolerance: Pan-
Hepatocyte proliferation
creas; (Rat); (Dog) (Berdeu, D. (324) 233)
EGF (epidermal growth factor); B-Adrenoceptor agonist; Forskolin; DNA
synthesis (Kimura, M. (324) 267)
Internalization
o@ Receptor; Cytotoxicity; Regulation; (+ )-Pentazocine; Desensitization
Heroin (Zambon, A.C. (324) 39)
Fentanyl; Morphine; 6-Acetylmorphine; Reinforcement (Martin, TJ. (324)
141) IRL 1620 (SucAla'-'-"*[ jenGdothlelinu-1-(’8-21 ))
Endothelin-|; Bosentan (4-tert-butyl-N-[6-(2-hydroxy-ethoxy )-5-(2-
Histamine receptor methoxy-phenoxy )-2,2’-bipyrimidin-4-yl}-benzene sulfonamide); FR
Plasma protein extravasation; 5-HT receptor; Tachykinin; Airways; Cap- 139317 ((R)24{(R)(-hex2ah-ydr{o-( |S H-)aze-pi2nyl-))[car[bo|ny! ) ami-
saicin; (Fisher 344 rat) (Germonpré, P.R. (324) 249) no-4-methypentanoilJamino-3-{3-(1-methyl- | H-indoy!)Jpropiony|jamino-
3-(2-pyridy!) propionic acid) (Takahashi, T. (324) 219)
5-HT (5-hydroxytryptamine, serotonin)
Substantia nigra reticulata; Antipsychotic; Schizophrenia; Basal ganglion; Isoprenaline
Electrophysiology: Dopamine (Bruggeman, R. (324) 49) Chelerythrine; Protein kinase C; Phosphodiesterase, cyclic nucleotide:
Vasorelaxation; SK& F 94120 (Eckly-Michel, A.E. (324) 85)
Phencyclidine; Antidepressant; Schizophrenia, negative symptom; De-
K * channel, Ca’ *-activated
pression; Forced swimming test; (Mouse) (Noda, Y. (324) 135)
Endothelin-1; Endothelin-3, Endothelin ET, receptor; Patch-clamp (Hu,
S. (324) 277)
Methamphetamine; Hyperthermia; Fluoxetine; Dopamine transport
(Fleckenstein, A.E. (324) 179)
Kidney
Angiotensin II; Norepinephrine; NOC 7 (1-hydroxy-2-oxo-34 N-methyl-
5-HT receptor
3-aminopropy!)-3-methy! |-triazene); Nitric oxide (NO), (Rabbit) (Adachi.
Plasma protein extravasation; Histamine receptor; Tachykinin; Airways;
Y. (324) 223)
Capsaicin; (Fisher 344 rat) (Germonpré, P.R. (324) 249)
Lamotrigine
Hyperalgesia
Neuropathic pain; Allodynia; Antinociception; Tail-flick test; Behavior;
NMDA receptor; Non-NMDA glutamate receptor; Nociception; Allody-
Electroshock test, maximal; Felbamate; Gabapentin (Hunter, J.C. (324)
nia; Inflammation; Pain (Lawand, N.B. (324) 169) 153)
Hyperplasia Leukocyte
Smooth muscle, vascular; Cell culture; Nifedipine; Captopril; Losartan: Albumin leakage; Lipopolysaccharide; 5-Lipoxygenase; Lung; Radioac-
Transgenic rat (Peiré, C. (324) 257) tive tracer (Bureau, M.F. (324) 89)
Hyperthermia Levcromakalim
Methamphetamine; Fluoxetine; Dopamine transport; 5-HT (5-hydroxy- Sulphonylurea; Thromboxane A,; U46619; Structure-activity relation-
tryptamine, serotonin) (Fleckenstein, A.E. (324) 179) ship; Coronary artery, pig (McPherson, G.A. (324) 193)
Ifenprodil Lipopolysaccharide
NMDA receptor; MK-801; 7-Chlorokynurenic acid; Diazepam with- Albumin leakage; 5-Lipoxygenase; Leukocyte; Lung; Radioactive tracer
drawal; (Mouse) (Tsuda, M. (324) 63) (Bureau, M.F. (324) 89)
Imidazoline 5-Lipoxygenase
Antazoline; Insulin secretion; Somatostatin secretion; Glucose tolerance; Albumin leakage; Lipopolysaccharide; Leukocyte: Lung: Radioactive
tracer (Bureau, M.F. (324) 89)
Pancreas; (Rat); (Dog) (Berdeu, D. (324) 233)
Losartan
Immediate-early gene
Hyperplasia; Smooth muscle, vascular; Cell culture; Nifedipine; Capto-
Amygdala, central; Bed nucleus of the stria terminalis; Paraventricular
pril; Transgenic rat (Peiré, C. (324) 257)
nucleus of the hypothalamus; Corticosterone; CRH (corticotropin-releas-
ing hormone) (Compaan, J.C. (324) 161)
Lung
Albumin leakage; Lipopolysaccharide; 5-Lipoxygenase; Leukocyte; Ra-
Immunoregulation dioactive tracer (Bureau, M.F. (324) 89)
Adjuvant arthritis; Cytokine (Conforti, A. (324) 241)
Memory
Inflammation R-+)-7-OH-DPAT (R-( + )-7-hydroxy-N, N-(di-n-propyl-2-aminoetra-
NMDA receptor; Non-NMDA glutamate receptor; Nociception; Hyperal- lin); Dopamine D, receptor; Passive avoidance learning; Spontaneous
gesia; Allodynia; Pain (Lawand, N.B. (324) 169) locomotor activity; (Mouse) (Ukai, M. (324) 147)
Keyword index 313
Methamphetamine NOC 7 (1-hydroxy-2-oxo-3- N-methyl-3-aminopropyl)-3-methyl 1-tri-
Hyperthermia; Fluoxetine; Dopamine transport; 5-HT (5-hydroxytrypta- azene)
mine, serotonin) (Fleckenstein, A.E. (324) 179) Angiotensin Il; Norepinephrine; Nitric oxide (NO); Kidney; (Rabbit)
(Adachi, Y. (324) 223)
S-Methyl-1-thiocitrulline
Morphine withdrawal; Blood pressure: Nitric oxide (NO) synthase in- Nociception
hibitor, 3-Bromo-7-nitro indazole; Aminoguanidine; 7-Nitro indazole: NMDA receptor; Non-NMDA glutamate receptor, Hyperalgesia: Allody-
Nitric oxide (NO) (Vaupel, D.B. (324) 11) nia; Inflammation; Pain (Lawand, N.B. (324) 169)
MK-801
Non-NMDA glutamate receptor
NMDA receptor; 7-Chlorokynurenic acid: Ifenprodil; Diazepam with-
NMDA receptor; Nociception: Hyperalgesia: Allodynia: Inflammation:
drawal; (Mouse) (Tsuda, M. (324) 63)
Pain (Lawand, N.B. (324) 169)
Zn** inhibition; NMDA receptor, binding; @ Receptor; Spinal cord;
(Mouse) (Kovaes, KJ. (324) 117)
Angiotensin Il; NOC 7 (1-hydroxy-2-oxo-34 N-methy!-3-aminopropy|)-
Morphine 3-methy! |-triazene), Nitric oxide (NO), Kidney: (Rabbit) (Adachi. Y.
Fentanyl; Heroin; 6-Acetylmorphine; Reinforcement (Martin, TJ. (324) (324) 223)
141)
R-+)-7-OH-DPAT (R-( +)-7-hydroxy-N, N-(di-n-propyl-2-amino)
Morphine withdrawal tetralin)
Blood pressure; Nitric oxide (NO) synthase inhibitor; 3-Bromo-7-nitro Dopamine D, receptor; Passive avoidance learning: Spontaneous locomo-
indazole; Aminoguanidine: S-Methyl-L-thiocitrulline; 7-Nitro indazole: tor activity; Memory; (Mouse) (Ukai, M. (324) 147)
Nitric oxide (NO) (Vaupel, D.B. (324) 11)
Okadaic acid
Muscarinic acetylcholine receptor-operated K * current Calyculin A; Phosphatase; Tumor cell locomotion; Walker 256 carci-
ATP, extracellular; Atrial cell; Purinoceptor; Action potential duration nosarcoma cell; Vimentin (Niggli, V. (324) 99)
(Hara, Y. (324) 295)
Opioid
Neuropathic pain Cocaine; Drug discrimination; Drug interaction (Suzuki, T. (324) 21)
Allodynia; Antinociception; Tail-flick test; Behavior, Electroshock test,
maximal; Lamotrigine; Felbamate; Gabapentin (Hunter, J.C. (324) 153)
DPDPE ([p.-p-PePn* eenknepha*lin ), 1-Opioid receptor knockout mouse
Nifedipine
(Sora, 1. (324) R1)
Hyperplasia; Smooth muscle, vascular; Cell culture; Captopril; Losartan;
Transgenic rat (Peiré, C. (324) 257)
«-Opioid receptor
Nitric oxide (NO) Fedotozine; ~-Opioid receptor; Visceral pain; Colonic hypersensitivity:
(Colonic distension) (Langlois, A. (324) 211)
Morphine withdrawal; Blood pressure: Nitric oxide (NO) synthase in-
hibitor; 3-Bromo-7-nitro indazole; Aminoguanidine; $-Methyl-.-thio-
citrulline, 7-Nitro indazole (Vaupel, D.B. (324) 11) p-Opioid receptor
Fedotozine; x-Opioid receptor; Visceral pain; Colonic hypersensitivity:
Angiotensin Il; Norepinephrine; NOC 7 (1-hydroxy-2-oxo-34 N-methyl- (Colonic distension) (Langlois, A. (324) 211)
3-aminopropy!)-3-methy! |-triazene); Kidney: (Rabbit) (Adachi, Y. (324)
223) p-Opioid receptor knockout mouse
DPDPE ([p.p--PePn* eenknepha’lin ), 5-Opioid receptor (Sora, 1. (324)
Prostacyclin; Glomerulonephritis (Ikeda, M. (324) 283) RI)
Nitric oxide (NO) synthase inhibitor Org 30029
Morphine withdrawal; Blood pressure; 3-Bromo-7-nitro indazole: Org 9935; Insulin secretion; Phosphodiesterase inhibitor; Insulin, plasma;
Aminoguanidine; $-Methyl-_-thiocitrulline; 7-Nitro indazole; Nitric oxide Glucose, plasma (El-Metwally, M. (324) 227)
(NO) (Vaupel, D.B. (324) 11)
Org 9935
7-Nitro indazole
Org 30029; Insulin secretion; Phosphodiesterase inhibitor, Insulin, plasma;
Morphine withdrawal; Blood pressure; Nitric oxide (NO) synthase in-
Glucose, plasma (El-Metwally, M. (324) 227)
hibitor, 3-Bromo-7-nitro indazole; Aminoguanidine; S-Methyl-L-thio-
citrulline; Nitric oxide (NO) (Vaupel, D.B. (324) 11)
Pain
NMDA receptor, Non-NMDA glutamate receptor; Nociception; Hyperal-
NMDA receptor
gesia; Allodynia; Inflammation (Lawand, N.B. (324) 169)
MK-801; 7-Chlorokynurenic acid; Ifenprodil; Diazepam withdrawal;
(Mouse) (Tsuda, M. (324) 63)
Palmitoylation
Non-NMDA glutamate receptor; Nociception; Hyperalgesia; Allodynia; Dopamine; Dopamine D, receptor; Adenylyl cyclase; Desensitization
Inflammation; Pain (Lawand, N.B. (324) 169) Vin, H. (324) 109)
NMDA receptor, binding Pancreas
Zn** inhibition; MK-801; o Receptor: Spinal cord; (Mouse) (Kovacs, Imidazoline; Antazoline; Insulin secretion; Somatostatin secretion; Glu-
KJ. (324) 117) cose tolerance; (Rat); (Dog) (Berdeu, D. (324) 233)
314 Keyword index
Paraventricular nucleus of the hypothalamus Ca** channel antagonist; Calmodulin; Tyrosine kinase; Smooth muscle
Immediate-early gene; Amygdala, central; Bed nucleus of the stria termi- contraction (Sim, S.-S. (324) 205)
nalis; Corticosterone; CRH (corticotropin-releasing hormone) (Compaan,
J.C. (324) 161) Pu
ATP, extracellular; Muscarinic acetylcholine receptor-operated K* cur-
Parkinson's disease rent; Atrial cell; Action potential duration (Hara, Y. (324) 295)
Dopamine transporter; WIN 35,428 binding; Arachidonic acid; Protein
kinase C; Drug abuse (Reith, M.E.A. (324) 1) Radioactive tracer
Albumin leakage; Lipopolysaccharide; 5-Lipoxygenase; Leukocyte; Lung
Passive avoidance learning (Bureau, M.F. (324) 89)
R-+)-7-OH-DPAT (R-(+ )-7-hydroxy-N, N-(di-n-propy|-2-amino)tetra-
lin); Dopamine D, receptor; Spontaneous locomotor activity; Memory; o Receptor
(Mouse) (Ukai, M. (324) 147) Cytotoxicity; Regulation; Internalization; (+ )-Pentazocine; Desensitiza-
tion (Zambon, A.C. (324) 39)
Patch-clamp
K* channel, Ca’ *-activated; Endothelin-1; Endothelin-3; Endothelin ET, Zn** inhibition; NMDA receptor, binding; MK-801; Spinal cord; (Mouse)
receptor (Hu, S. (324) 277) (Kovaes, K.J. (324) 117)
( +)-Pentazocine Regulation
o Receptor; Cytotoxicity; Regulation; Internalization; Desensitization o Receptor; Cytotoxicity; Internalization; (+ )-Pentazocine; Desensitiza-
(Zambon, A.C. (324) 39)
tion (Zambon, A.C. (324) 39)
Phencyclidine Reinforcement
Antidepressant; Schizophrenia, negative symptom; Depression; 5-HT (5-
Fentanyl; Heroin; Morphine; 6-Acetylmorphine (Martin, TJ. (324) 141)
hydroxytryptamine, serotonin); Forced swimming test; (Mouse) (Noda, Y.
(324) 135)
Reperfusion arrhythmia
Pinacidil; Cromakalim; Glibenclamide; Anesthetized rat (Baczk6, |. (324)
Phosphatase
77)
Okadaic acid; Calyculin A; Tumor cell locomotion; Walker 256 carci-
nosarcoma cell; Vimentin (Niggli, V. (324) 99)
Schizophrenia
Substantia nigra reticulata; Antipsychotic; Basal ganglion; Electro-
Phosphodiesterase, cyclic nucleotide
physiology; Dopamine; 5-HT (5-hydroxytryptamine, serotonin) (Brugge-
Chelerythrine; Protein kinase C; Vasorelaxation; SK &F 94120; Isopre-
man, R. (324) 49)
naline (Eckly-Michel, A.E. (324) 85)
Schizophrenia, negative symptom
inhibitor
Phencyclidine; Antidepressant; Depression; 5-HT (5-hydroxytryptamine,
Org 9935; Org 30029; Insulin secretion; Insulin, plasma; Glucose, plasma
serotonin); Forced swimming test; (Mouse) (Noda, Y. (324) 135)
(El-Metwally, M. (324) 227)
Pinacidil SK &F 94120
Reperfusion arrhythmia; Cromakalim; Glibenclamide; Anesthetized rat Chelerythrine; Protein kinase C; Phosphodiesterase, cyclic nucleotide;
(Baczk6, I. (324) 77) Vasorelaxation; Isoprenaline (Eckly-Michel, A.E. (324) 85)
Smooth muscle contraction
Plasma protein extravasation
5-HT receptor; Histamine receptor; Tachykinin; Airways; Capsaicin; Ca** channel antagonist; Protein kinase C; Calmodulin; Tyrosine kinase
(Fisher 344 rat) (Germonpré, P.R. (324) 249) (Sim, S.-S. (324) 205)
Polymerase chain reaction Smooth muscle, vascular
Tachykinin NK , receptor, expression; Uterus, rat (Pinto, F.M. (324) 125) Hyperplasia; Cell culture; Nifedipine; Captopril; Losartan; Transgenic rat
(Peiré, C. (324) 257)
Pramipexole
Dopamine receptor agonist; Antipsychotic potential activity; Antiparkin- Somatostatin secretion
sonian potential activity (Maj, J. (324) 31) Imidazoline; Antazoline; Insulin secretion; Glucose tolerance; Pancreas:
(Rat); (Dog) (Berdeu, D. (324) 233)
Pranidipine (OPC-13340)
Ca** channel antagonist; Circulatory filling pressure, mean; Venodilator Spinal cord
effect; (Rat) (Hirano, T. (324) 201) Zn** inhibition; NMDA receptor, binding; MK-801; o Receptor; (Mouse)
(Kovaes, KJ. (324) 117)
Prostacyclin
Nitric oxide (NO); Glomerulonephritis (Ikeda, M. (324) 283) s locomotor activity
R-4+)-7-OH-DPAT (R- + )-7-hydroxy-N, N-(di-n-propy!-2-amino}etra-
Protein kinase C lin); Dopamine D, receptor; Passive avoidance learning: Memory:
Dopamine transporter, WIN 35,428 binding; Arachidonic acid; Parkin- (Mouse) (Ukai, M. (324) 147)
son's disease; Drug abuse (Reith, M.E.A. (324) 1)
SR 141716A
Chelerythrine; Phosphodiesterase, cyclic nucleotide; Vasorelaxation; SK Cannabinoid receptor: CP 55,940; Brain slice; Acetylcholine (Gifford,
& F 94120; Isoprenaline (Eckly-Michel, A.E. (324) 85) A.N. (324) 187)